Literature DB >> 26116096

Tumor necrosis factor-alpha single nucleotide polymorphisms in juvenile systemic lupus erythematosus.

Fatemeh Tahghighi1, Vahid Ziaee2, Mohammad Hassan Moradinejad3, Arezou Rezaei4, Sara Harsini4, Samaneh Soltani5, Maryam Sadr5, Maryam Mahmoudi6, Yahya Aghighi7, Nima Rezaei8.   

Abstract

BACKGROUND: Juvenile systemic lupus erythematosus (JSLE) is a multi-system autoimmune disorder of unknown origin. Given the importance of the contribution of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), towards the pathogenesis of JSLE, this study was performed to assess TNFA gene polymorphisms in a case-control study.
METHODS: Fifty nine patients with JSLE were enrolled in this study as case group and compared with healthy control subjects. The frequency of alleles, genotypes, and haplotypes of TNFA single-nucleotide polymorphisms (SNPs) at positions -308 and -238 were evaluated, using polymerase chain reaction with sequence-specific primers method.
RESULTS: The G allele at position -238 in TNFA promoter region was significantly more frequent in patients with JSLE than in the healthy controls (P value<0.001), while the frequency of A allele at the same position was significantly lower than controls. Furthermore, a significant positive association for G/G genotype at the same position was detected in patients' group compared with control subjects (P value<0.001). The GA haplotype of TNFA (positions -308, -238) was significantly less frequent in case group than in controls (P value<0.001), while GG was the most frequent haplotype for TNFA in the patient group, compared to controls (P value<0.01).
CONCLUSIONS: Pro-inflammatory cytokine gene polymorphisms may influence susceptibility to JSLE. Particular TNFA gene variants are associated with JSLE and could be used as a genetic marker for susceptibility to JSLE.
Copyright © 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Juvenile systemic lupus erythematosus; Single-nucleotide polymorphism; Tumor necrosis factor-alpha

Mesh:

Substances:

Year:  2015        PMID: 26116096     DOI: 10.1016/j.humimm.2015.06.011

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis.

Authors:  Vahid Ziaee; Marzieh Maddah; Mohammad-Hassan Moradinejad; Arezou Rezaei; Samaneh Zoghi; Maryam Sadr; Sara Harsini; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2016-09-20       Impact factor: 2.980

2.  Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis.

Authors:  Vahid Ziaee; Arezou Rezaei; Sara Harsini; Marzieh Maddah; Samaneh Zoghi; Maryam Sadr; Mohammad Hassan Moradinejad; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2016-03-07       Impact factor: 2.980

3.  Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.

Authors:  Chen-Xing Zhang; Li Cai; Kang Shao; Jing Wu; Wei Zhou; Lan-Fang Cao; Tong-Xin Chen
Journal:  Pediatr Nephrol       Date:  2017-12-20       Impact factor: 3.714

4.  Interleukin-2 and Interferon-Gamma Single Nucleotide Polymorphisms in Iranian Patients with Chronic Heart Failure.

Authors:  Mohammad Jafar Mahmoudi; Sara Harsini; Elham Farhadi; Mona Hedayat; Mohammad Taghvaei; Maryam Mahmoudi; Maryam Sadr; Nilufar Esfahanian; Ebrahim Nematipour; Keramat Nourijelyani; Ali Akbar Amirzargar; Nima Rezaei
Journal:  Avicenna J Med Biotechnol       Date:  2018 Jul-Sep

5.  Interleukin-10 and Transforming Growth Factor Beta1 Gene Polymorphisms in Chronic Heart Failure.

Authors:  Mohammad Jafar Mahmoudi; Mona Hedayat; Mohammad Taghvaei; Sara Harsini; Ebrahim Nematipour; Nima Rezaei; Elham Farhadi; Maryam Mahmoudi; Maryam Sadr; Nilufar Esfahanian; Keramat Nourijelyani; Ali Akbar Amirzargar
Journal:  Acta Biomed       Date:  2019-05-23

6.  Association between TNF-ɑ-308G/A polymorphism and esophageal cancer risk: An updated meta-analysis and trial sequential analysis.

Authors:  Fengming Yang; Ke Wei; Zhiqiang Qin; Chuchu Shao; Yongqian Shu; Hua Shen
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.